<DOC>
	<DOCNO>NCT02083107</DOCNO>
	<brief_summary>The aim work evaluate &amp; compare effectiveness rectally administer PGE1 synthetic analogue ( misoprostol ) 400 microgram versus sublingually administer misoprostol caesarean section decrease blood loss operation .</brief_summary>
	<brief_title>Comparison Between Rectal &amp; Sublingual Misoprostol Before Caesarian Section To Reduce Intra &amp; Post-Operative Blood Loss</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Postoperative Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>1 . Patients book elective cesarean section . 2 . Singleton pregnancy . 3 Full term pregnancy ( GA 3742 week ) . 4 Patients previous one cesarian section 1 . Primigravida . 2 . Blood dyscrasia . 3 . Large fibroid . 4 . Multiple pregnancy . 5 . Overdistended uterus eg . Hydramnios . 6 . Preeclampsia . 7 . Marked maternal anemia ( Preoperative hemoglobin &lt; 9 gm/dl ) . 8 . Previous history PPH . 9 . Contraindications prostaglandin therapy ( e.g . history severe bronchial asthma allergy misoprostol . 10 . Placenta previa . 11 . Contraindication spinal anesthesia . 12 . Previous myomectomy . 13 . Previous two C.S .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Postpartum hemorrhage</keyword>
	<keyword>Intrapartum blood loss</keyword>
	<keyword>Misoprostol</keyword>
</DOC>